Peptide Inhibitors

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
R2200 RAD16-I hydrochloride 1749.2 C66H114ClN29O25
R2201 Polymyxin B nonapeptide TFA 1533.3 C53H79F15N14O21
R2202 J-2156 TFA 582.6 C26H29F3N4O6S
R2203 D-Ala-Lys-AMCA hydrochloride 468.9 C21H29ClN4O6
R2204 Pal-Gly-His-Lys-OH trifluoroacetate 692.8 C32H55F3N6O7
R2205 Substance P(1-7) (TFA) 1014.1 C43H66F3N13O12
R2206 Biotinoyl-Tripeptide-1 trifluoroacetate 680.7 C26H39F3N8O8S
R2207 PHI 27 (human) trifluoroacetate 3099.4 C137H215F3N34O42S
R2208 Lactoferrin acetate 3183.8 C143H228N46O31S3
R2209 Semax acetate(free base) 874 C39H55N9O12S
R2210 Gamma-glutamylcysteine (TFA) 364.3 C10H15F3N2O7S
R2211 RADA16-I 1712.8 C66H113N29O25
R2212 β-Endorphin (rat) 3466 C157H254N42O44S
R2213 Mif-1 (tfa) 398.38 C15H25F3N4O5
R2214 Brevianamide F 283.32 C16H17N3O2
R2215 Cyclo(-RGDfK) Trifluoroacetate 717.7 C29H42F3N9O9
R2216 Neurotensin acetate salt 1672.9 C78H121N21O20
R2217 Cosyntropin acetate 2993.5 C138H214N40O33S
R2218 Fibrinopeptide A, human tfa 1749.6 C67H98F6N18O30
R2219 S 2238 552.6 C27H36N8O5